References
1.
Gallardo R, Kranwinkel RN: Pseudo-Chédiak-Higashi anomaly. Am J Clin Pathol 1985;83:127-129.
2.
Symes PH, Williams ME, Flessa HC, Srivastava AK, Swerdlow SH: APL with pseudo-Chédiak-Higashi anomaly and molecular documentation of t(15;17) chromosomal translocation. Am J Clin Pathol 1993;99:622-627.
3.
Markovic N: Chédiak-Higashi-like granules in acute promyelocytic leukemia. Blood 1998;92:3475-3477.
4.
Powari M, Varma N, Varma S, Komal HS: Pseudo-Chédiak Higashi anomaly in an Indian patient with acute myeloid leukemia (AML-M2). Am J Hematol 2000;65:324-325.
5.
Golovleva I, Hultdin J, Roos G, Wahlin A, Holgrem G: Coexistence of pseudo-Chédiak-Higashi anomaly and double minutes containing c-myc oncogene in three patients with AML M2. Leukemia 2002;16:152-154.
6.
Bozkaya IO, Yarali N, Sac RU, Tavil B, Kara A, Azik F, Tunç B: Pseudo-Chediak-Higashi anomaly in acute myeloid leukemia with t (8;21). J Pediatr Hematol Oncol 2012;34:242.
7.
Abdulsalam AH, Sabee N, Bain BJ: Pseudo-Chédiak-Higashi inclusions together with Auer rods in acute myeloid leukemia. Am J Hematol 2011;86:602.
8.
Kakkar N, Das S, Joseph JM: Pseudo Chediak Higashi inclusions in a patient with acute myeloblastic leukemia. Indian J Cancer 2010;47:81-82.
9.
Hamanaka SC, Gilbert CS, White DA, Parmely RT: Ultrastructure morphology, cytochemistry, and morphometry of eosinophil granules in Chédiak-Higashi syndrome. Am J Pathol 1993;143:618-627.
10.
Fegan CD, White D, Sweeney M: C-myc amplification, double minutes and homogenous staining regions in a case of AML. Br J Haematol 1995;90:486-488.
11.
Shaffer LG, Slovak ML, Campbell LJ (eds): ISCN (2013): An International System for Human Cytogenetic Nomenclature. Basel, Karger, 2013.
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.